Increased [18F]FMISO accumulation under hypoxia by multidrug-resistant protein 1 inhibitors
Abstract Background [18F]Fluoromisonidazole ([18F]FMISO) is a PET imaging probe widely used for the detection of hypoxia. We previously reported that [18F]FMISO is metabolized to the glutathione conjugate of the reduced form in hypoxic cells. In addition, we found that the [18F]FMISO uptake level va...
Main Authors: | Yoichi Shimizu, Yukihiro Nakai, Hiroyuki Watanabe, Shimpei Iikuni, Masahiro Ono, Hideo Saji, Yuji Kuge, Tsuneo Saga, Yuji Nakamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-01-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13550-021-00752-3 |
Similar Items
-
Elimination of tumor hypoxia by eribulin demonstrated by 18F-FMISO hypoxia imaging in human tumor xenograft models
by: Songji Zhao, et al.
Published: (2019-06-01) -
First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer
by: Sébastien Thureau, et al.
Published: (2021-08-01) -
Comparison of FDG and FMISO uptakes and distributions in head and neck squamous cell cancer tumors
by: Sadek A. Nehmeh, et al.
Published: (2021-04-01) -
Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET
by: Nicole Wiedenmann, et al.
Published: (2018-08-01) -
FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer
by: Martin Dolezel, et al.
Published: (2022-07-01)